261 related articles for article (PubMed ID: 19531488)
1. The effects of nitroxyl (HNO) on soluble guanylate cyclase activity: interactions at ferrous heme and cysteine thiols.
Miller TW; Cherney MM; Lee AJ; Francoleon NE; Farmer PJ; King SB; Hobbs AJ; Miranda KM; Burstyn JN; Fukuto JM
J Biol Chem; 2009 Aug; 284(33):21788-21796. PubMed ID: 19531488
[TBL] [Abstract][Full Text] [Related]
2. The concomitant coronary vasodilator and positive inotropic actions of the nitroxyl donor Angeli's salt in the intact rat heart: contribution of soluble guanylyl cyclase-dependent and -independent mechanisms.
Chin KY; Qin C; Cao N; Kemp-Harper BK; Woodman OL; Ritchie RH
Br J Pharmacol; 2014 Apr; 171(7):1722-34. PubMed ID: 24372173
[TBL] [Abstract][Full Text] [Related]
3. Soluble guanylate cyclase is required for systemic vasodilation but not positive inotropy induced by nitroxyl in the mouse.
Zhu G; Groneberg D; Sikka G; Hori D; Ranek MJ; Nakamura T; Takimoto E; Paolocci N; Berkowitz DE; Friebe A; Kass DA
Hypertension; 2015 Feb; 65(2):385-92. PubMed ID: 25452469
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms underlying activation of soluble guanylate cyclase by the nitroxyl donor Angeli's salt.
Zeller A; Wenzl MV; Beretta M; Stessel H; Russwurm M; Koesling D; Schmidt K; Mayer B
Mol Pharmacol; 2009 Nov; 76(5):1115-22. PubMed ID: 19720727
[TBL] [Abstract][Full Text] [Related]
5. Nitroxyl: a vasodilator of human vessels that is not susceptible to tolerance.
Andrews KL; Lumsden NG; Farry J; Jefferis AM; Kemp-Harper BK; Chin-Dusting JP
Clin Sci (Lond); 2015 Jul; 129(2):179-87. PubMed ID: 25728899
[TBL] [Abstract][Full Text] [Related]
6. Redox variants of NO (NO{middle dot} and HNO) elicit vasorelaxation of resistance arteries via distinct mechanisms.
Favaloro JL; Kemp-Harper BK
Am J Physiol Heart Circ Physiol; 2009 May; 296(5):H1274-80. PubMed ID: 19252101
[TBL] [Abstract][Full Text] [Related]
7. The trans effect of nitroxyl (HNO) in ferrous heme systems: implications for soluble guanylate cyclase activation by HNO.
Goodrich LE; Lehnert N
J Inorg Biochem; 2013 Jan; 118():179-86. PubMed ID: 23146743
[TBL] [Abstract][Full Text] [Related]
8. Heme-assisted S-nitrosation desensitizes ferric soluble guanylate cyclase to nitric oxide.
Fernhoff NB; Derbyshire ER; Underbakke ES; Marletta MA
J Biol Chem; 2012 Dec; 287(51):43053-62. PubMed ID: 23093402
[TBL] [Abstract][Full Text] [Related]
9. The Influence of Nitric Oxide on Soluble Guanylate Cyclase Regulation by Nucleotides: ROLE OF THE PSEUDOSYMMETRIC SITE.
Sürmeli NB; Müskens FM; Marletta MA
J Biol Chem; 2015 Jun; 290(25):15570-15580. PubMed ID: 25907555
[TBL] [Abstract][Full Text] [Related]
10. Nitric oxide and heat shock protein 90 activate soluble guanylate cyclase by driving rapid change in its subunit interactions and heme content.
Ghosh A; Stasch JP; Papapetropoulos A; Stuehr DJ
J Biol Chem; 2014 May; 289(22):15259-71. PubMed ID: 24733395
[TBL] [Abstract][Full Text] [Related]
11. HNO/cGMP-dependent antihypertrophic actions of isopropylamine-NONOate in neonatal rat cardiomyocytes: potential therapeutic advantages of HNO over NO.
Irvine JC; Cao N; Gossain S; Alexander AE; Love JE; Qin C; Horowitz JD; Kemp-Harper BK; Ritchie RH
Am J Physiol Heart Circ Physiol; 2013 Aug; 305(3):H365-77. PubMed ID: 23729209
[TBL] [Abstract][Full Text] [Related]
12. A nitric oxide/cysteine interaction mediates the activation of soluble guanylate cyclase.
Fernhoff NB; Derbyshire ER; Marletta MA
Proc Natl Acad Sci U S A; 2009 Dec; 106(51):21602-7. PubMed ID: 20007374
[TBL] [Abstract][Full Text] [Related]
13. A constitutively activated mutant of human soluble guanylyl cyclase (sGC): implication for the mechanism of sGC activation.
Martin E; Sharina I; Kots A; Murad F
Proc Natl Acad Sci U S A; 2003 Aug; 100(16):9208-13. PubMed ID: 12883009
[TBL] [Abstract][Full Text] [Related]
14. Effects of nitroglycerin/L-cysteine on soluble guanylate cyclase: evidence for an activation/inactivation equilibrium controlled by nitric oxide binding and haem oxidation.
Gorren AC; Russwurm M; Kollau A; Koesling D; Schmidt K; Mayer B
Biochem J; 2005 Sep; 390(Pt 2):625-31. PubMed ID: 15907191
[TBL] [Abstract][Full Text] [Related]
15. Nitric oxide-independent vasodilator rescues heme-oxidized soluble guanylate cyclase from proteasomal degradation.
Meurer S; Pioch S; Pabst T; Opitz N; Schmidt PM; Beckhaus T; Wagner K; Matt S; Gegenbauer K; Geschka S; Karas M; Stasch JP; Schmidt HH; Müller-Esterl W
Circ Res; 2009 Jul; 105(1):33-41. PubMed ID: 19478201
[TBL] [Abstract][Full Text] [Related]
16. Nitroxyl (HNO) stimulates soluble guanylyl cyclase to suppress cardiomyocyte hypertrophy and superoxide generation.
Lin EQ; Irvine JC; Cao AH; Alexander AE; Love JE; Patel R; McMullen JR; Kaye DM; Kemp-Harper BK; Ritchie RH
PLoS One; 2012; 7(4):e34892. PubMed ID: 22506056
[TBL] [Abstract][Full Text] [Related]
17. Regeneration of the ferrous heme of soluble guanylate cyclase from the nitric oxide complex: acceleration by thiols and oxyhemoglobin.
Brandish PE; Buechler W; Marletta MA
Biochemistry; 1998 Dec; 37(48):16898-907. PubMed ID: 9836582
[TBL] [Abstract][Full Text] [Related]
18. Dissociation of nitric oxide from soluble guanylate cyclase and heme-nitric oxide/oxygen binding domain constructs.
Winger JA; Derbyshire ER; Marletta MA
J Biol Chem; 2007 Jan; 282(2):897-907. PubMed ID: 17098738
[TBL] [Abstract][Full Text] [Related]
19. Structure of cinaciguat (BAY 58-2667) bound to Nostoc H-NOX domain reveals insights into heme-mimetic activation of the soluble guanylyl cyclase.
Martin F; Baskaran P; Ma X; Dunten PW; Schaefer M; Stasch JP; Beuve A; van den Akker F
J Biol Chem; 2010 Jul; 285(29):22651-7. PubMed ID: 20463019
[TBL] [Abstract][Full Text] [Related]
20. Inactivation of soluble guanylate cyclase by stoichiometric S-nitrosation.
Mayer B; Kleschyov AL; Stessel H; Russwurm M; Münzel T; Koesling D; Schmidt K
Mol Pharmacol; 2009 Apr; 75(4):886-91. PubMed ID: 19114587
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
